Literature DB >> 28621082

Editorial: tackling hepatorenal syndrome-terlipressin for all, or time for a stratified approach?

F J Gifford1, J A Fallowfield2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28621082     DOI： 10.1111/apt.14098

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

1.  Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome.

Authors:  Kevin Moore; Khurram Jamil; Katharina Verleger; Linlin Luo; Nehemiah Kebede; Marieke Heisen; Shelby Corman; Roberta Leonardi; Rachel Bakker; Christine Maï; Nisreen Shamseddine; Xingyue Huang; Andrew S Allegretti
Journal:  Aliment Pharmacol Ther       Date:  2020-06-04       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.